Approvals/NMPA/Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）

Approved

化学药品

Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）

成都地奥制药集团有限公司🇨🇳 National Medical Products Administration

Approval Id: 8nJBRhaNMbK
Approval Number: 国药准字H20255205
Generic Name: 恩格列净二甲双胍缓释片(Ⅳ)
Generic Name En: Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 恩格列净25mg与盐酸二甲双胍1000mg
Reg Date: 2025-08-26
Company Name: 成都地奥制药集团有限公司
Company Address: 成都市高新区高新大道创业路26号
Production Company Name: 广州玻思韬控释药业有限公司
Production Company Address: 广州市黄埔区瑞祥路228号
Company Detail Path: /organization/cheng-du-di-ao-zhi-yao-ji-tuan-you-xian-gong-si
Production Company Detail Path: /organization/yan-zhou-bo-si-tao-kong-shi-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 26, 2025

Approval ID

8nJBRhaNMbK

Type

化学药品